These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11553852)

  • 1. Cell cycle activation of peripheral blood stem and progenitor cells expanded ex vivo with SCF, FLT-3 ligand, TPO, and IL-3 results in accelerated granulocyte recovery in a baboon model of autologous transplantation but G0/G1 and S/G2/M graft cell content does not correlate with transplantability.
    Drouet M; Herodin F; Norol F; Mourcin F; Mayol JF
    Stem Cells; 2001; 19(5):436-42. PubMed ID: 11553852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood.
    De Bruyn C; Delforge A; Martiat P; Bron D
    Stem Cells Dev; 2005 Aug; 14(4):415-24. PubMed ID: 16137231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo expanded mobilized peripheral blood CD34+ cells accelerate haematological recovery in a baboon model of autologous transplantation.
    Norol F; Drouet M; Mathieu J; Debili N; Jouault H; Grenier N; Laplanche A; Vainchenker W; Hérodin F
    Br J Haematol; 2000 Apr; 109(1):162-72. PubMed ID: 10848796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reduction of in vitro radiation-induced Fas-related apoptosis in CD34+ progenitor cells by SCF, FLT-3 ligand, TPO, and IL-3 in combination resulted in CD34+ cell proliferation and differentiation.
    Drouet M; Mathieu J; Grenier N; Multon E; Sotto JJ; Herodin F
    Stem Cells; 1999; 17(5):273-85. PubMed ID: 10527462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
    Traycoff CM; Abboud MR; Laver J; Clapp DW; Srour EF
    Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-induced expansion of human CD34+ stem/progenitor and CD34+CD41+ early megakaryocytic marrow cells cultured on normal osteoblasts.
    Ahmed N; Khokher MA; Hassan HT
    Stem Cells; 1999; 17(2):92-9. PubMed ID: 10195569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-acting cytokine-driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post-mitotic offspring with preserved engraftment ability in non-obese diabetic/severe combined immunodeficient mice.
    Herrera C; Sánchez J; Torres A; Bellido C; Rueda A; Alvarez MA
    Br J Haematol; 2001 Sep; 114(4):920-30. PubMed ID: 11564087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice.
    Gothot A; van der Loo JC; Clapp DW; Srour EF
    Blood; 1998 Oct; 92(8):2641-9. PubMed ID: 9763545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rate of marrow recovery and extent of donor engraftment following transplantation of ex vivo-expanded bone marrow cells are independently influenced by the cytokines used for expansion.
    von Drygalski A; Savatski L; Eastwood D; Klein J; Adamson JW
    Stem Cells Dev; 2005 Oct; 14(5):564-75. PubMed ID: 16305341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
    Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
    Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of culture conditions to enhance transfection of human CD34+ cells by electroporation.
    Wu MH; Smith SL; Danet GH; Lin AM; Williams SF; Liebowitz DN; Dolan ME
    Bone Marrow Transplant; 2001 Jun; 27(11):1201-9. PubMed ID: 11551032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopetrotic mouse stroma with thrombopoietin, c-kit ligand, and flk-2 ligand supports long-term mobilized CD34+ hematopoiesis in vitro.
    Feugier P; Li N; Jo DY; Shieh JH; MacKenzie KL; Lesesve JF; Latger-Cannard V; Bensoussan D; Crystal RG; Rafii S; Stoltz JF; Moore MA
    Stem Cells Dev; 2005 Oct; 14(5):505-16. PubMed ID: 16305336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor.
    Ueda T; Tsuji K; Yoshino H; Ebihara Y; Yagasaki H; Hisakawa H; Mitsui T; Manabe A; Tanaka R; Kobayashi K; Ito M; Yasukawa K; Nakahata T
    J Clin Invest; 2000 Apr; 105(7):1013-21. PubMed ID: 10749580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engraftment of primates with G-CSF mobilized peripheral blood CD34+ progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia.
    Andrews RG; Briddell RA; Hill R; Gough M; McNiece IK
    Stem Cells; 1999; 17(4):210-8. PubMed ID: 10437984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease in apoptosis and increase in polyploidization of megakaryocytes by stem cell factor during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin.
    Kie JH; Yang WI; Lee MK; Kwon TJ; Min YH; Kim HO; Ahn HS; Im SA; Kim HL; Park HY; Ryu KH; Chung WS; Shin MH; Jung YJ; Woo SY; Park HK; Seoh JY
    Stem Cells; 2002; 20(1):73-9. PubMed ID: 11796924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of mouse bone marrow cells with kit ligand, FLT3 ligand, and thrombopoietin leads to efficient retrovirus-mediated gene transfer to stem cells, whereas interleukin 3 and interleukin 11 reduce transduction of short- and long-term repopulating cells.
    Wognum AW; Visser TP; Peters K; Bierhuizen MF; Wagemaker G
    Hum Gene Ther; 2000 Oct; 11(15):2129-41. PubMed ID: 11044914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
    Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
    Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.